Dipeptidyl peptidase-4 inhibition to prevent progression of calcific aortic stenosis

OBJECTIVE: To evaluate whether the use of dipeptidyl peptidase-4 (DPP-4) inhibitors and their cardiac tissue distribution profile and anticalcification abilities are associated with risk of aortic stenosis (AS) progression. METHODS: Out of the five different classes of DPP-4 inhibitors, two had rela...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Heart
Prif Awduron: Lee, Sahmin, Lee, Seung-Ah, Choi, Bongkun, Kim, Ye-Jee, Oh, Soo Jin, Choi, Hong-Mi, Kim, Eun Kyoung, Kim, Dae-Hee, Cho, Goo-Yeong, Song, Jong-Min, Park, Seung Woo, Kang, Duk-Hyun, Song, Jae-Kwan
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BMJ Publishing Group 2020
Pynciau:
Valvular Heart Disease
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7677484/
https://ncbi.nlm.nih.gov/pubmed/32917732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/heartjnl-2020-317024
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg